| P50 | author | Vittorio Pengo | Q42778559 |
| P2093 | author name string | Alessandra Banzato | |
| P2860 | cites work | Circulating levels of beta2-glycoprotein I in thrombotic disorders and in inflammation | Q82835521 |
| | Circulating β2 glycoprotein I-IgG anti-β2 glycoprotein I immunocomplexes in patients with definite antiphospholipid syndrome | Q84227566 |
| | Association between beta2-glycoprotein I plasma levels and the risk of myocardial infarction in older men | Q84465030 |
| | Studies on the possible function of beta 2-glycoprotein-I: influence in the triglyceride metabolism in the rat | Q24302454 |
| | Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. | Q27619832 |
| | Crystal structure of human β2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome | Q27620388 |
| | beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface | Q28285122 |
| | Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis | Q35928720 |
| | Complete amino acid sequence of human plasma beta 2-glycoprotein I. | Q36262293 |
| | Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I. | Q37095385 |
| | β₂-glycoprotein I: a novel component of innate immunity. | Q39567484 |
| | The primary structure of rat beta 2-glycoprotein I. | Q40452588 |
| | Prevalence of beta2-glycoprotein I antibody in patients with liver cirrhosis: relationship with beta2-glycoprotein I plasma levels and thrombosis | Q47739764 |
| | β2 -Glycoprotein I binds to thrombin and selectively inhibits the enzyme procoagulant functions. | Q51074186 |
| | Beta2-glycoprotein-I plasma levels in liver cirrhosis. | Q51774908 |
| | A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I | Q64355639 |
| | Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome | Q70839159 |
| | Elevated levels of beta 2 glycoprotein-I (beta 2 GPI) in antiphospholipid antibody syndrome are due to increased amounts of beta 2 GPI in association with other plasma constituents | Q70971400 |
| | Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels | Q72046201 |
| | Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages | Q73149303 |
| | beta(2)-glycoprotein I deficiency: prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis | Q74348150 |
| | Glycoproteins of human plasma | Q76494774 |
| | Estimation of plasma beta-2-glycoprotein levels by competitive ELISA | Q77476210 |
| | Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies | Q77909438 |
| | Genetic variation in the apolipoprotein H (beta2-glycoprotein I) gene affects plasma apolipoprotein H concentrations | Q78237699 |
| | [On the problem of the chemical structure of plasma proteins.] | Q79025115 |
| P433 | issue | 6 | |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 424 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Clinical relevance of β₂-glycoprotein-I plasma levels in antiphospholipid syndrome (APS). | |
| P478 | volume | 16 | |